Clinical Trial Update: ERADICATE Hp - Treating Helicobacter Pylori With RHB-105 [Phase 3]

View source ↗

Summary

Phase 3 trial update for ERADICATE Hp evaluating RHB-105 to treat Helicobacter pylori infection; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyspepsia
• Helicobacter Pylori Infection

Drugs mentioned

• RHB-105

Snippet

Sponsor: RedHill Biopharma Limited | Conditions: Dyspepsia, Helicobacter Pylori Infection | Phase 3 | Status: COMPLETED | Results posted: 2017-01-10